ArticleJAMA network open2026
Protein Intake and Kidney Outcomes in Nondialysis Chronic Kidney Disease Over 15 Years.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Error in Figure 3.JAMA network open · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: The optimal dietary protein intake (DPI) for patients with chronic kidney disease (CKD) remains uncertain. Long-term, clinical practice data using objective DPI measures are limited, and concerns about nutritional risk persist. Objective: To evaluate the association of objectively measured DPI with long-term kidney and clinical outcomes in adults with CKD stages 3 and 4. Design, Setting, and Participants: This retrospective cohort study included adults with CKD stages 3 and 4 receiving care in Clalit Health Services, Israel, with index entry from January 1, 2007, through December 31, 2022, and follow-up of up to 15 years. DPI was assessed using 24-hour urinary nitrogen excretion and normalized to adjusted body weight (normalized DPI [nDPI]). Participants were stratified by an nDPI threshold of 1.0 g/kg/d (selected using time-dependent receiver operating characteristic analysis). Data were analyzed from August to October 2025. Exposure: nDPI calculated from 24-hour urinary nitrogen excretion, analyzed dichotomously using the 1.0 g/kg/d threshold. Main Outcomes and Measures: The primary outcome was a composite of 50% or more decline in estimated glomerular filtration rate (eGFR), initiation of long-term dialysis, or all-cause mortality. Secondary outcomes included individual components and trajectories of eGFR and albuminuria. Propensity score matching was used to balance baseline characteristics between lower (<1.0 g/kg/d) and higher (≥1.0 g/kg/d) nDPI groups. Kidney function was evaluated using mixed-effects models and joint models linking eGFR trajectories with time-to-event outcomes. Results: Of 1441 included patients (mean [SD] age, 67.20 [11.26] years; 507 [35.2%] women), 530 were matched (265 per group). During follow-up, the lower-nDPI group had a lower risk of the composite outcome (hazard ratio [HR], 0.77; 95% CI, 0.62-0.97; log-rank P = .03), mainly related to fewer dialysis initiations (HR, 0.65; 95% CI, 0.42-0.99). In adjusted Cox models, low nDPI remained associated with lower composite risk (HR, 0.75; 95% CI, 0.60-0.93). Longitudinal models showed no significant between-group differences in eGFR or albuminuria slopes; eGFR decline was numerically slower in the low-nDPI group (slope difference, 0.152 mL/min/1.73 m2/y). No differences in nutritional markers were observed. Conclusions and Relevance: In this retrospective cohort study of adults with CKD stages 3 and 4, lower nDPI (<1.0 g/kg/d) was associated with lower dialysis risk without nutritional harm. These findings support moderate protein restriction with routine DPI monitoring in CKD care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.